topotecan has been researched along with gadolinium dtpa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankiewicz, KS; Bringas, JR; Dugich-Djordjevic, M; Eastman, S; Grahn, AY; Hadaczek, P; Johnson, GA; Luz, M | 1 |
| Arias-Mendoza, F; Bagiella, E; Brown, T; Bruce, JN; Bruce, SS; Canoll, P; Dashnaw, S; Mohajed, H; Romanov, A; Sebastian, M; Sonabend, AM; Stuart, RM; Yanagihara, T; Yun, J | 1 |
2 other study(ies) available for topotecan and gadolinium dtpa
| Article | Year |
|---|---|
Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Survival; Contrast Media; Convection; Drug Delivery Systems; Gadolinium DTPA; Glioblastoma; Humans; Liposomes; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Survival Rate; Tissue Distribution; Topotecan; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.
Topics: Animals; Brain Neoplasms; Contrast Media; Convection; Drug Delivery Systems; Gadolinium DTPA; Glioma; Humans; Image Processing, Computer-Assisted; Infusion Pumps, Implantable; Infusions, Subcutaneous; Liposomes; Magnetic Resonance Imaging; Male; Swine; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 2011 |